Objective: Myocardial injury after noncardiac surgery (MINS) refers to prognostically relevant myocardial injury due to ischemia that occurs during or within 30 days after noncardiac surgery (NCS). Its prognostic impact has recently been established, so that MINS has been independently associated with 30-day mortality after NCS, and any detectable cardiac troponin T (cTnT; 0.01 ng/mL) is associated with increased longterm mortality after vascular surgery. The characteristics and prognostic importance of MINS in vascular surgery patients are poorly described, and the prevalence of MINS in endovascular aneurysm repair (EVAR) patients is unknown. Also, most studies use fourth-generation cTnT, which can have significant baseline increases in chronic kidney disease patients. Unlike cTnT, cardiac troponin I (cTnI) is more specific for myocardial injury in chronic kidney disease patients. This work aimed to evaluate the prevalence of MINS in EVAR patients and its impact on all-cause mortality using contemporary cTnI and high-sensitivity troponin I (hSTnI) measurements.
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Two-Device Closure Method for LargeDiameter Arteriotomies in Percutaneous Endovascular Aortic Repair
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Objective: Percutaneous endovascular aortic repairs are associated with access site complications. As endovascular devices become more sophisticated and frequently require large-bore arteriotomies, several devices and techniques have been described to aid in the percutaneous closure of arteriotomies, including collagen plug devices (Angio-Seal; Terumo Interventional Systems, Somerset, NJ) and percutaneous suturemediated closure devices (Perclose; Abbott Vascular, Santa Clara, Calif). Two-device preclose technique using two Perclose devices has been well established. Combined Perclose and Angio-Seal technique has been described for arteriotomies up to 14F because of instances of only a single Perclose device successfully predeployed during the preclose technique. We sought to determine whether a hybrid Perclose and Angio-Seal closure technique would safely and effectively establish hemostasis in large-bore arteriotomies up to 20F.
Methods: Before sheath insertion, one Perclose device was predeployed. At the end of percutaneous endovascular aortic repair, device sheath and introducer were withdrawn over a 0.035-inch wire, and partially deployed Perclose was fully deployed. The sheath and introducer were fully withdrawn, and the arteriotomy was closed with a 6F Angio-Seal vascular closure device. Patients were observed at day 1 and day 30 and at least 1 year after intervention.
Results: A composite end point of complications was defined as an access site-related bleed or hematoma or retroperitoneal hematoma that required blood transfusion, pseudoaneurysm, arteriovenous fistula, or dissection. The combined technique was initially successful in 44 of 46 arteriotomies (95.6%) in 24 of 26 patients (92.3%) with no conversions to cutdown. Sheath sizes ranged from 10F to 20F outer diameter (OD), with an average of 15.85F OD. In the two instances in which satisfactory hemostasis using this method was not initially achieved, Perclose failure and Angio-Seal failure each accounted for a singled episode and required manual compression. Both instances occurred in a 20F arteriotomy. The only late complication of this method was a subcentimeter pseudoaneurysm in the arteriotomy where the perclose device did not deploy. There were no other early or late complications in this series.
Conclusions: Large-bore arteriotomies can be safely and effectively closed using a hybrid percutaneous closure technique for sheaths up to 19F OD. Further investigation is needed to assess the value of this closure in 20F OD sheaths and above. Objective: Duplex ultrasound (DU) is a viable alternative to computed tomography angiography (CTA) for follow-up of patients undergoing standard endovascular aneurysm repair (EVAR). However, the efficacy of DU as a follow-up modality in patients undergoing more complex reconstructions, such as fenestrated EVAR (FEVAR) and chimney EVAR (ChEVAR), is not well known. For these patients, in addition to the presence of endoleak and aneurysm growth, the sonographer must be able to identify patency of renal and visceral stents. In this study, we evaluate our experience of DU follow-up in patients undergoing FEVAR and ChEVAR.
Methods: A total of 82 consecutive patients undergoing FEVAR and ChEVAR were retrospectively reviewed. The patients' follow-up regimen consisted of postoperative DU at 1 month followed by CTA at 3 months. Data on aortic dimensions, presence of endoleaks, patency of renal and visceral stents, and postoperative complications were collected and analyzed.
Results: Of the 82 patients, 38 (46.3%) thoracoabdominal aneurysms, 41 (50.0%) juxtarenal aneurysms, and 3 (3.7%) suprarenal aneurysms were evaluated. The mean age was 75.6 (standard deviation, 61.3) years, and there were 54 (66.7%) men. The breakdown of procedures included 39 (47.6%) ChEVARs and 43 (52.4%) FEVARs, 10 (12.2%) of which were reinterventions after previous EVAR. The 30-day follow-up rate was 80.3% of patients, of whom 53 (80.3%) received an initial DU examination. There were 4 (7.6%) endoleaks without growth and 3 (5.7%) endoleaks with growth discovered and subsequently intervened on; the other 46 (86.8%) scans were unremarkable. The 3-month follow-up rate was 59.2% of patients, of whom 29 (64.4%) received CTA. Of the patients who initially had an unremarkable 1-month DU examination, 9 (19.6%) were lost to follow-up; of the remaining 37 patients, 32 (86.5%) had unremarkable 3-month scans, whereas 2 (5.4%) new endoleaks without growth, 2 (5.4%) endoleaks with growth, and 1 (2.7%) visceral branch occlusion were discovered. Sac regression at 3 months was observed in 47.4% of patients for a mean reduction of 4.8 mm. The 30-day mortality rate was 4.9% and represented three cases of bowel ischemia and one
